Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection

BACKGROUND: Tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are recommended as the first-line choices regarding the treatment of chronic hepatits B. The impact of the two antiviral agents on prognosis of Chronic hepatitis B (CHB) related hepatocellular carcinoma (HCC) remains to be explored....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Min, Wang, Dexin, Liu, Haidong, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994044/
https://www.ncbi.nlm.nih.gov/pubmed/29977330
http://dx.doi.org/10.1186/s13027-018-0191-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994044/
https://www.ncbi.nlm.nih.gov/pubmed/29977330
http://dx.doi.org/10.1186/s13027-018-0191-8

Ejemplares similares